Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
342
Frequently Asked Questions
What is Market Cap of Arcutis Biotherapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Arcutis Biotherapeutics Inc market cap is $2.08B.
What is the 52-week high for Arcutis Biotherapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Arcutis Biotherapeutics Inc 52 week high is $17.75 as of September 10, 2025.
What is the 52-week low for Arcutis Biotherapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Arcutis Biotherapeutics Inc 52 week low is $8.03 as of September 10, 2025.
What is Arcutis Biotherapeutics Inc stock price today?
Arcutis Biotherapeutics Inc stock price today is $17.93.
What was Arcutis Biotherapeutics Inc stock price yesterday?
Arcutis Biotherapeutics Inc stock price yesterday was $17.33.
What is the PE ratio of Arcutis Biotherapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Arcutis Biotherapeutics Inc’s P/E ratio is -23.28.
What is the Price-to-Book ratio of Arcutis Biotherapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Arcutis Biotherapeutics Inc P/B ratio is 14.9388.
What is the 50-day moving average of Arcutis Biotherapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Arcutis Biotherapeutics Inc 50-day moving average is $15.13.
How many employess does Arcutis Biotherapeutics Inc has?